HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xiao-Ming Xu Selected Research

bisperoxovanadium

1/2019Bisperoxovanadium Mediates Neuronal Protection through Inhibition of PTEN and Activation of PI3K/AKT-mTOR Signaling after Traumatic Spinal Injuries.
2/2015Biphasic bisperoxovanadium administration and Schwann cell transplantation for repair after cervical contusive spinal cord injury.
6/2014PTEN inhibitor bisperoxovanadium protects oligodendrocytes and myelin and prevents neuronal atrophy in adult rats following cervical hemicontusive spinal cord injury.
1/2012Systemic bisperoxovanadium activates Akt/mTOR, reduces autophagy, and enhances recovery following cervical spinal cord injury.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xiao-Ming Xu Research Topics

Disease

55Spinal Cord Injuries (Spinal Cord Injury)
01/2022 - 06/2003
12Inflammation (Inflammations)
07/2021 - 06/2002
12Wounds and Injuries (Trauma)
01/2019 - 06/2008
6Neoplasms (Cancer)
01/2021 - 06/2010
5Gliosis
02/2016 - 03/2004
4Atrophy
01/2021 - 06/2014
4Demyelinating Diseases (Demyelinating Disease)
01/2016 - 04/2006
4Nervous System Diseases (Neurological Disorders)
05/2011 - 01/2004
3Traumatic Brain Injuries (Traumatic Brain Injury)
12/2020 - 01/2019
3Breast Neoplasms (Breast Cancer)
11/2016 - 01/2013
2Hemorrhage
06/2019 - 09/2018
2Contusions
11/2017 - 06/2014
2Prostatic Neoplasms (Prostate Cancer)
08/2017 - 02/2016
2Adenomatous Polyposis Coli (Familial Adenomatous Polyposis)
02/2010 - 07/2005
1Muscular Atrophy (Muscle Atrophy)
01/2021
1Adenocarcinoma
01/2021
1Neuroinflammatory Diseases
12/2020
1Body Weight (Weight, Body)
07/2020
1Hypotension (Low Blood Pressure)
07/2020
1Heat Stroke (Heatstroke)
07/2020
1Hyperthermia
07/2020
1Myocardial Infarction
09/2019
1Infarction (Infarctions)
09/2019
1Spinal Injuries (Spinal Injury)
01/2019
1Stroke (Strokes)
01/2019
1Weight Loss (Weight Reduction)
01/2019
1Acute Coronary Syndrome
09/2018
1Pancreatic Neoplasms (Pancreatic Cancer)
01/2018
1Renal Cell Carcinoma (Grawitz Tumor)
12/2016

Drug/Important Bio-Agent (IBA)

8Phospholipases A2 (Phospholipase A2)IBA
01/2021 - 04/2006
8Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA
01/2021 - 06/2003
6Neuroprotective AgentsIBA
01/2021 - 10/2004
6Proteins (Proteins, Gene)FDA Link
09/2019 - 08/2004
5salicylhydroxamic acid (SHAM)IBA
01/2021 - 08/2012
4bisperoxovanadiumIBA
01/2019 - 01/2012
4Protein Isoforms (Isoforms)IBA
09/2015 - 03/2004
4Phospholipases (Phospholipase)IBA
12/2011 - 08/2004
3Testosterone (Sustanon)FDA Link
06/2018 - 08/2012
3Pharmaceutical PreparationsIBA
11/2016 - 06/2011
2Laminin (Merosin)IBA
01/2021 - 06/2006
2TensinsIBA
01/2019 - 01/2012
2Phosphoric Monoester Hydrolases (Phosphatases)IBA
01/2019 - 01/2012
2Dihydrotestosterone (Androstanolone)IBA
06/2018 - 01/2018
2Estradiol (Delestrogen)FDA LinkGeneric
06/2018 - 01/2018
2baysilon (polydimethylsiloxane)IBA
01/2018 - 08/2012
2rho-Associated KinasesIBA
11/2017 - 01/2016
2Cyclin D1IBA
08/2017 - 06/2016
2Biomarkers (Surrogate Marker)IBA
08/2017 - 01/2016
2Messenger RNA (mRNA)IBA
08/2017 - 08/2004
2ORALIT (ORS)IBA
06/2016 - 04/2014
2Neurotransmitter Agents (Neurotransmitter)IBA
03/2016 - 11/2009
2Glial Fibrillary Acidic ProteinIBA
02/2016 - 06/2011
2Biological ProductsIBA
09/2015 - 01/2004
2DNA (Deoxyribonucleic Acid)IBA
11/2014 - 09/2011
2Chondroitin Sulfate ProteoglycansIBA
06/2011 - 03/2004
2MicroRNAs (MicroRNA)IBA
05/2011 - 10/2009
2EnzymesIBA
03/2011 - 08/2004
2Nonesterified Fatty Acids (NEFA)IBA
06/2010 - 06/2008
2Secretory Phospholipases A2IBA
11/2009 - 06/2008
2VaccinesIBA
12/2008 - 05/2007
2Myelin Basic ProteinIBA
11/2008 - 07/2005
1Phosphotransferases (Kinase)IBA
01/2022
1PlasticsIBA
01/2022
1LipopolysaccharidesIBA
07/2021
1arachidonyltrifluoromethaneIBA
01/2021
1alpha-Fetoproteins (alpha-Fetoprotein)IBA
01/2021
1MelatoninIBA
12/2020
1AntioxidantsIBA
07/2020
1myricetinIBA
07/2020
1FlavonoidsIBA
07/2020
1Nitric Oxide Synthase Type I (Neuronal Nitric Oxide Synthase)IBA
01/2020
1N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
01/2020
1Creatine Kinase (Creatine Phosphokinase)IBA
09/2019
1L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
09/2019
1Matrix Metalloproteinases (MMPs)IBA
09/2019
1Small Interfering RNA (siRNA)IBA
09/2019
1Troponin T (Troponin T1)IBA
09/2019
1Troponin IIBA
09/2019
1Therapeutic UsesIBA
06/2019
1Pro-Opiomelanocortin (Proopiomelanocortin)IBA
01/2019
1Fatty Acids (Saturated Fatty Acids)IBA
01/2019
1Clopidogrel (Plavix)FDA Link
09/2018
1TicagrelorIBA
09/2018
1Gonadal HormonesIBA
06/2018
1ErbB Receptors (EGF Receptor)IBA
01/2018
1Erlotinib Hydrochloride (CP 358,774)FDA Link
01/2018
1Cadherins (E-Cadherin)IBA
01/2018
1Y 27632IBA
11/2017
1Lipase (Acid Lipase)FDA Link
11/2017
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
08/2017
1fucoidanIBA
08/2017
1Hemoglobins (Hemoglobin)IBA
08/2017
1Cantharidin (Cantharides)IBA
12/2016

Therapy/Procedure

11Transplantation
01/2021 - 04/2004
6Therapeutics
01/2022 - 10/2011
3Injections
03/2016 - 04/2006
2Lasers (Laser)
01/2019 - 01/2017
2Laminectomy
01/2019 - 05/2016
1Percutaneous Coronary Intervention
09/2018
1Aftercare (After-Treatment)
08/2017